Biocompatible oligo-oxazoline crosslinkers: Towards advanced chitosans for controlled dug release

Research output: Contribution to journalArticlepeer-review


Chitosan, a natural and abundant biopolymer has been long explored as a biocompatible material for the preparation of drug delivery devices. This strategy has been mostly accomplished using chemically crosslinked chitosan leading to more stable scaffolds. However, crosslinking has been shown to reduce both biocompatibility and swelling. In this work chitosan was crosslinked with novel biocompatible crosslinkers, based on oligo-oxazolines and glycidyl methacrylate copolymers, leading to patches with a very high swelling capacity. Dexamethasone therapeutics is strongly enhanced by a controlled release administration. This study shows that oligo-oxazoline-crosslinked chitosan is a suitable biomaterial for loading and controlled release of dexamethasone.

Original languageEnglish
Article number104846
JournalReactive and Functional Polymers
Publication statusPublished - Apr 2021


  • Chitosan
  • Crosslinking
  • Dexamethasone
  • Oligo-oxazolines
  • Supercritical carbon dioxide


Dive into the research topics of 'Biocompatible oligo-oxazoline crosslinkers: Towards advanced chitosans for controlled dug release'. Together they form a unique fingerprint.

Cite this